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Abstract  Diffuse  lepromatous  leprosy  (DLL)  is  a  severe  clinical  outcome  of  lepromatous  le-
prosy (LL).  The  aetiologic  cause  is  believed  to  be  different  from  Mycobacterium  leprae.
A new  species,  Mycobacterium  lepromatosis,  was  identiﬁed  from  a  group  of  Mexican  patients
with DLL,  and  severe  leprosy  reactional  state  type  3  (Lucio’s  phenomenon).  However,  a  total
sequencing  of  its  genome  is  necessary  to  prove  the  existence  of  this  new  species.  This  is  a  report
on a  non-typical  Colombian  case  of  leprosy  --  HIV  coinfection,  associated  with  an  immune  recon-
stitution inﬂammatory  syndrome  clinically  compatible  with  a  leprosy  reaction  type  3  or  Lucio’s
phenomenon.
© 2016  ACIN.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an  open  access  article  under  the  CC
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Lepromatous  leprosy  and  human  immunodeﬁciency  virus  273
PALABRAS  CLAVE
Lepra;
Fenómeno  de  Lucio;
Síndrome  de
reconstitución
inmunológica  (SRI);
Virus  de
Inmunodeﬁciencia
Humana  (VIH);
Terapia
antirretroviral  de
gran  actividad
(HAART);
Mycobacterium
leprae;
Mycobacterium
Lepra  lepromatosa  y  coinfección  con  el  virus  de  la  inmunodeﬁciencia  humana
asociada  a  fenómeno  de  Lucio  versus  síndrome  inﬂamatorio  de  reconstitución  inmune
Resumen  La  lepra  difusa  (LLD)  es  una  variedad  de  la  lepra  lepromatosa  (LL),  frecuente  en
México. El  agente  etiológico  se  cree  que  es  diferente  a  Mycobacterium  leprae  y  se  considera
una especie  nueva  denominada  Mycobacterium  lepromatosis,  hecho  que  no  se  ha  comprobado.
El reporte  de  este  caso  se  realiza  para  dar  a  conocer  el  cuadro  clínico  atípico  que  presentó
una paciente  colombiana  con  coinfección  VIH--LL  variedad  difusa  (LLD),  asociado  a  síndrome
de reconstitución  inmunológica,  compatible  clínicamente  con  una  leprorreacción  tipo  3  o  fenó-
meno de  Lucio.
©  2016  ACIN.  Publicado  por  Elsevier  Espan˜a,  S.L.U.  Este  es  un  art´ıculo  Open  Access  bajo  la
licencia CC  BY-NC-ND  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
d
3
a
d
h
o
r
d
w
H
p
n
i
(
n
d
4
c
s
l
a
p
l
t
a
h
o
p
i
l
o
e
tlepromatosis
Introduction
Diffuse  lepromatous  leprosy  (DLL)  is  a  severe  clinical  out-
come  of  lepromatous  leprosy.  A  new  species,  Mycobacterium
lepromatosis,  was  identiﬁed  from  a  group  of  Mexican
patients  with  DLL,  and  severe  leprosy  reactional  state  type
3  (phenomenon  of  Lucio),  however  total  sequence  of  its
genome  is  necessary  to  probe  the  existence  of  this  new
species.1
The  phenomenon  of  Lucio  was  described  for  Lucio  and
Alvarado  in  1852  and  it  was  redeﬁned  by  Latapí  in  1948,
until  now  this  reactional  outcome  is  object  of  debate
for  clinicians  and  scientists  due  to  its  confuse  pathogen-
esis.  Clinically,  the  immune  hypersensitivity  triggered  by
bacterial  antigens  is  associated  with  constitutional  symp-
toms,  necrotizing  vasculitis,  sepsis,  and  in  some  cases
death.2--4
In  addition,  the  advent  of  human  immunodeﬁciency  virus
(HIV)  and  routine  use  of  highly  effective  antiretroviral  the-
rapy  (HAART)  in  patients  with  Hansen’s  disease  may  relate
to  other  events  as  immune  reconstitution  inﬂammatory  syn-
drome  (IRIS),  which  may  occur  in  40%  of  patients  with  HIV
and  HAART.5,6 This  syndrome  characterizes  by  a  paradoxi-
cal  inﬂammatory  condition  because  of  immune  restoration
generated  by  antiretrovirals.  In  patients  with  HIV-leprosy,
IRIS  has  been  generally  associated  with  inﬂammatory  pro-
cesses  such  leprosy-reactions  type1,  in  contrast  current
clinical  case  shows  a  leprosy  reaction  type  3  or  phenomenon
of  Lucio.3,4,7,8
Case description
Colombian  female  patient,  37  years  old,  on  July  2013  con-
sulted  by  one  month  of  recurrent  febrile  episodes  and
multiple  skin  ulcers  in  lower  limbs  since  one  year  ago.  On
physical  examination  patient  has  signs  as  pinna  oedema,
loss  of  the  bilateral  external  third  of  eyebrows,  chronic
indurated  lesions  in  abdomen,  pigmented  scarring  lesions
in  lower  limbs  that  patient  refers  as  an  episode  of  ulcers
c
p
p
suring  the  pregnancy  in  2006.  Patient  relates  that  since
 years  ago,  her  skin  began  to  become  smooth  and  shiny,
ssociated  with  occasional  nosebleeds,  headache  and  ten-
erness  inﬁltration  in  hands  and  feet.  In  addition,  patient
as  skin  ulcers  with  burning  pain  associated  with  local
edema  and  serous-hematic  and  purulent  discharge.  Patient
efers  weight  loss  of  4  kg  in  6  months.  She  relates  that  seven
ays  ago  her  spouse  died  by  AIDS.  Patient  was  hospitalized
ith  study  diagnosis  of  ecthyma  gangrenosum,  vasculitis  by
IV,  anaemia,  sepsis,  and  leprosy.
Laboratory  exams:  haemoglobin  6,9;  red  cells  mor-
hology  microcytic  hypochromic,  leukocytes  3.300,  70%
eutrophils,  platelets  230.000.  Functional  hepatic  tests
n  normal  ranges.  Skin  biopsy  reported  bacillary  index
BI)  =  3  plus.  Patient  diagnosed  as  DLL  and  Lucio’s  phe-
omenon.  Multidrug  therapy  (MDT-MB)  initiated  with
apsone  +  rifampicin  +  clofazimine.  HIV  viral  load  was
80.474  copies/ml;  CD4/CD8  =  0.8%,  total  CD4T  lympho-
ytes  (helper):  170  cells/l, total  CD8T  cells  (cytotoxic
uppressor):  202  cells/l; CD3T  lymphocyte  subpopu-
ations:  377  cells/l). Besides  MDT,  patient  received
bacavir/lamivudine  plus  lopinavir/ritonavir.
After  three  weeks  of  treatment  for  HIV  and  leprosy,  the
atient  consulted  for  fever  associated  with  multiple  bullous
esions  with  reticular  pattern  in  upper  limbs  and  proximal
hird  of  the  lower  extremities.  In  addition,  lesions  ulcerated
re  evident  with  erythematous,  dirty  background,  serum-
ematic  secretion,  some  with  necrotic  aspect,  and  signs
f  inﬂammation  and  infection.  Also,  refers  numbness  and
aresthesias  in  the  hands  and  feet  (Figs.  1  and  2).
Physical  examination  reported  a  malnourished  patient,
n  poor  general  conditions,  bilateral  inﬁltration  in  auricu-
ar  lobes,  thinning  of  the  nasal  septum,  and  some  skin
edematous  lesions  in  abdomen.  Simpliﬁed  neurological
xamination  showed  thickening  and  pain  on  palpation  of
he  auricular,  ulnar,  median,  radial,  posterior  tibial,  and
ommon  ﬁbular  nerves,  with  anaesthesia  in  glove  and  sock
attern  (hands  and  feet),  also  mild  resorption  of  the  distal
halanx  of  the  ﬁfth  ﬁnger  of  left  hand.  The  rest  of  the  phy-
ical  exam  described  a  patient  with  well  cardiopulmonary
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Figures  1  and  2  Bullous  lesions  and  phlyctenules  of  ery-
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thematous  borders,  irregulars,  compatible  with  necrotizing
asculitis  (Lucio’s  phenomenon).
onditions,  no  evidence  of  masses  or  organ  enlargement  in
bdomen.
Complementary  tests  included  serology  for  detection
f  IgM  antibodies  to  phenolic  glycolipid  1  (PGL-1),  exhi-
ited  high  positive  titters.  Furthermore,  DNA  extracted  from
kin  biopsy  tested  by  Sanger  sequencing  technique  was
erformed  in  Professor  Stewart  Cole’s  laboratory  (Global
ealth  Institute,  Ecole  Polytechnique  Fédérale  de  Lau-
anne,  Switzerland);  ruling  out  the  infection  caused  by
.  lepromatosis.  Results  reported  M.  leprae  European  geno-
ype  3-I  as  the  cause  of  DLL.
After  two  months  of  hospitalization  and  medical
anagement  with  antiretrovirals,  MDT-MB,  trimethoprim
ulfamethoxazole  160/800  mg  and  rifampin  600  mg  per  day,
he  patient  was  discharged  due  to  favourable  clinical  evo-
ution,  showing  healing  of  skin  lesions  in  upper  and  lower
imbs  (Fig.  3),  and  improvement  of  HIV  viral  load.
The  patient  did  not  receive  treatment  with  thalidomide
nd/or  steroids  as  it  is  recommended  for  some  authors,6
he  patient  received  600  mg/day  of  rifampicin  as  the  only
easure  to  treat  Lucio  reaction.9
i
t
wFigure  3  Scars  of  lesions  in  lower  limbs  after  treatment.
iscussion
his  case  reports  an  atypical  type  3  reaction  in  a  LL--HIV
oinfection  after  HAART.  Patient  had  a  diagnosis  of  phe-
omenon  of  Lucio  based  in  clinical  symptoms  (cutaneous
listers,  bullae,  skin  sloughing  and  necrotizing  vasculitis
nvolving  upper  and  lower  limb  areas),10,11 and  she  was
reated  for  Lucio  reaction  with  rifampicin  600  mg  per  day.
owever,  it  is  noteworthy  that  IRIS  in  patients  with  Hansen’s
isease  is  often  associated  to  reaction  type  1,  usually  within
he  ﬁrst  six  months  after  initiation  of  HAART,  or  in  patients
ith  advanced  stages  of  HIV  can  occur  in  an  earlier  time.6--8
Another  non-typical  case  was  reported  in  India  by
rakkal  et  al,12 in  which  described  a  patient  with  HIV  and
RIS,  associated  with  erythema  nodosum  leprosum  (ENL),
hich  allowed  unmask  silent  lepromatous  infection  after
our  weeks  of  starting  HAART.  In  addition,  Cusini  et  al.13
escribed  a  case  of  a Brazilian  man  living  in  Switzerland
nfected  with  HIV  and  manifestations  of  ENL  and  LL  after
tarting  HAART,  which  was  classiﬁed  as  a  rare  form  of  IRIS.
herefore,  different  states  reactional  to  LR1  as  ENL  or  Lucio
henomenon  could  be  generated  as  a  result  of  IRIS  expres-
ion  in  patients  with  HIV  co-infection  leprosy,  shortly  after
tarting  HAART.12,13
The  pathophysiological  mechanisms  responsible  for  IRIS
re  known  incompletely.  This  syndrome  is  believed  to  be  the
esult  of  immune  reconstitution  unbalanced  way  of  effec-
or  and  regulatory  T  cells  in  patients  receiving  antiretroviral
herapy.  Immune  reconstitution  during  HAART  generates  the
xpression  of  regulatory  T  cells  that  may  be  defective  in  its
unction  and  in  number,  thus  inhibiting  their  ability  to  sup-
ress  the  expression  of  pro-inﬂammatory  cytokines,  which
ould  be  responsible  for  the  appearance  of  focal  and  sys-
emic  signs  and  symptoms  of  inﬂammation.14,15
One  deduction  that  arises  for  this  atypical  clinical  case  is
hat  due  to  the  high  bacillary  load,  added  to  an  improvement
n  immune  response  caused  by  HAART  allowed  the  forma-
ion  of  immune  complexes  (IC).  These  IC  deposited  in  the
alls  of  capillaries  and  arterioles  triggering  the  migration
11
1
1
1
AIDS (Auckl). 2015;7:49--64.
15. Sharma SK, Soneja M. HIV & immune reconstitution inﬂamma-
tory syndrome (IRIS). Indian J Med Res. 2011;134(DecemberLepromatous  leprosy  and  human  immunodeﬁciency  virus  
of  phagocytic  and  inﬂammatory  cells  thereby  causing  clini-
cal  symptoms  of  necrotizing  vasculitis  that  could  resemble
a  phenomenon  of  Lucio.  The  atypical  clinical  manifesta-
tions  described  after  starting  HAART  could  be  explained  by
the  activation  of  TH1  response,  which  generates  increased
activity  of  macrophages,  activation  of  complement  and  gen-
eration  of  inﬂammatory  cytokines  (IL6,  IL10,  IL22).  This
response  of  immune  hypersensitivity  type  3,  allowed  the
emergence  of  ulcerative  lesions  resulting  from  thrombosis
in  the  deep  and  superﬁcial  vessels,  which  generated  the
sloughing  of  large  areas  of  skin,  associated  with  vesicles,
blisters  and  bullae.2--4,8,10
M.  lepromatosis  has  been  postulated  as  the  causal  agent
of  DLL  and  phenomenon  of  Lucio,1 however,  although  it  was
suspected  that  M.  lepromatosis  was  causing  this  clinical
case,  it  was  ruled  out,  conﬁrming  M.  leprae.
Therefore,  this  shows  how  far  we  know  about  clinical  and
immunological  aspects  of  leprosy,11 which  arises  the  need  for
further  research  to  understand  and  visualize  the  complexity
of  these  phenomena  of  immune  hypersensitivity  affecting
patients  with  Hansen’s  disease,  limiting  their  quality  of  life
or  sometimes  leading  them  to  death  by  our  lack  of  knowl-
edge  of  these  special  cases.
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